{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:33:53Z","timestamp":1787564033696,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1551"],"award-info":[{"award-number":["SFB 1551"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["464588647"],"award-info":[{"award-number":["464588647"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1066"],"award-info":[{"award-number":["SFB1066"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148058","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:09:13Z","timestamp":1759360153000},"page":"148058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations"],"prefix":"10.1016","volume":"330","author":[{"given":"Ana Pena","family":"Vaquero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Calderon-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Rivero-Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jos\u00e9","family":"Limeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Fraude-El","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Huck-Iriart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius U.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano L.","family":"Cacicedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Lieberwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Landfester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina Alba","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tekiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German A.","family":"Islan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148058_bb0005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0015","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1105655","article-title":"Review: current trends, challenges, and success stories in adjuvant research","volume":"14","author":"Singleton","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101427","article-title":"mRNA-LNP vaccine strategies: effects of adjuvants on non-parenchymal liver cells and tolerance","volume":"33","author":"Svensson","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0030","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.vaccine.2014.12.072","article-title":"Monophosphoryl lipid a coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage","volume":"33","author":"Fichter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0035","first-page":"1","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41590-022-01168-4","article-title":"Making innate sense of mRNA vaccine adjuvanticity","volume":"23","author":"Kobiyama","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0050","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12026-024-09456-x","article-title":"Monophosphoryl lipid a as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection","volume":"72","author":"Mirshekar","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152132","article-title":"Monophosphoryl lipid a directly regulates Th1 cytokine production in human CD4+ T-cells through toll-like receptor 2 and 4","volume":"226","author":"Komai-Koma","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-Adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update","volume":"20","author":"Lee","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0090","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3389\/fimmu.2019.03018","article-title":"Lipid nanoparticles potentiate CpG-Oligodeoxynucleotide-based vaccine for influenza virus","volume":"10","author":"Shirai","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301687","article-title":"Lipid nanoparticle delivery alters the Adjuvanticity of the TLR9 agonist CpG by innate immune activation in lymphoid tissue","volume":"12","author":"Zhong","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.virs.2022.06.002","article-title":"LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix\u2122 in VZV-primed mice","volume":"37","author":"Luan","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2024.04.052","article-title":"Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria","volume":"370","author":"Meulewaeter","year":"2024","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.03.041","article-title":"Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses","volume":"357","author":"Pan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100103","article-title":"Overview of vaccine adjuvants","volume":"11","author":"Wu","year":"2021","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/erv.10.154","article-title":"Combination adjuvants: the next generation of adjuvants?","volume":"10","author":"Mutwiri","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00430-018-0545-2","article-title":"Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid a) and naloxone-enhanced Th1 immune response to the plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice","volume":"207","author":"Nazeri","year":"2018","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104149","article-title":"Combined TLR4 and TLR9 agonists induce distinct phenotypic changes in innate immunity in vitro and in vivo","volume":"355","author":"Lampe","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/pharmaceutics16060771","article-title":"Optimizing mRNA-loaded lipid nanoparticles as a potential tool for protein-replacement therapy","volume":"16","author":"Gambaro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0150","author":"Rasband"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1107\/S1600576715004306","article-title":"The fast azimuthal integration Python library: pyFAI","volume":"48","author":"Ashiotis","year":"2015","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0160","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011254","article-title":"Encapsulation of dexamethasone into mRNA-lipid nanoparticles is a promising approach for the development of liver-targeted anti-inflammatory therapies","volume":"25","author":"Rivero Berti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.xphs.2021.01.005","article-title":"Binary medical Nanofluids by combination of polymeric Eudragit nanoparticles for Vehiculization of tobramycin and resveratrol: antimicrobial, Hemotoxicity and protein Corona studies","volume":"110","author":"Toledo","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0190","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0195","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41578-021-00413-w","article-title":"Regulating trained immunity with nanomedicine","volume":"7","author":"van Leent","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0215","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/pharmaceutics15082045","article-title":"Cytotoxic screening and enhanced anticancer activity of Lippia alba and Clinopodium nepeta essential oils-loaded biocompatible lipid nanoparticles against lung and Colon Cancer cells","volume":"15","author":"Rodenak-Kladniew","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0225","first-page":"2383","article-title":"MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells, nanomedicine Nanotechnol","volume":"12","author":"Pietrzak-Nguyen","year":"2016","journal-title":"Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlae007","article-title":"Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes","volume":"9","author":"Dollinger","year":"2025","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2018.06.004","article-title":"MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine","volume":"156","author":"Ko","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0240","article-title":"Cellular uptake and retention of nanoparticles: insights on particle properties and interaction with cellular components","volume":"25","author":"Augustine","year":"2020","journal-title":"Mater Today Commun"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013 what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303370","article-title":"Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omtm.2022.07.006","article-title":"mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model","volume":"26","author":"Cacicedo","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.smim.2017.08.015","article-title":"Delivering the right message: challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics\u2014an innate immune system standpoint","volume":"34","author":"Granot","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914820","article-title":"The dual role of the innate immune system in the effectiveness of mRNA therapeutics","volume":"24","author":"Muslimov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0270","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/vaccines9080820","article-title":"Using adjuvants to drive T cell responses for next-generation infectious disease vaccines","volume":"9","author":"Rapaka","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0275","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1201044","article-title":"IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling","volume":"190","author":"Hoge","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0280","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03018","article-title":"Lipid nanoparticles potentiate CpG-Oligodeoxynucleotide-based vaccine for influenza virus","volume":"10","author":"Shirai","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0295","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/v14071493","article-title":"Understanding immune responses to viruses\u2014do underlying Th1\/Th2 cell biases predict outcome?","volume":"14","author":"Howard","year":"2022","journal-title":"Viruses"},{"issue":"28","key":"10.1016\/j.ijbiomac.2025.148058_bb0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.cji.0000163594.74533.10","article-title":"IL-12 production by human monocyte-derived dendritic cells: looking at the single cell","volume":"1997","author":"Muller-Berghaus","year":"2005","journal-title":"J. Immunother. Hagerstown Md"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0305","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI68395","article-title":"IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity","volume":"123","author":"Carreno","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/srep33234","article-title":"PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro","volume":"6","author":"Hung","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution of RNA vaccines and of their products: evidence from human and animal studies","volume":"12","author":"Pateev","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300351","article-title":"Recent advances of emerging spleen-targeting Nanovaccines for immunotherapy","volume":"12","author":"He","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0325","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.3390\/ijms22158044","article-title":"Review of dendritic cells, their role in clinical immunology, and distribution in various animal species","volume":"22","author":"Zanna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0330","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2011.03.007","article-title":"Plasmacytoid dendritic cells mature independently of MyD88 and IFN-\u03b1\u03b2R in response to Listeria and stimulate CD8 T cells","volume":"138","author":"Tam","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0335","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/cells11203328","article-title":"mRNA-based approaches to treating liver diseases","volume":"11","author":"Cacicedo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121457","article-title":"Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance","volume":"283","author":"Casey","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0345","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.7150\/thno.44960","article-title":"Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.148058_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acsinfecdis.2c00424","article-title":"Synthetic stimulator of interferon genes (STING) agonists induce a cytokine-mediated anti-hepatitis B virus response in nonparenchymal liver cells","volume":"9","author":"Pimkova Polidarova","year":"2023","journal-title":"ACS Infect. Dis."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025086155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025086155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:13:17Z","timestamp":1778667197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025086155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":70,"alternative-id":["S0141813025086155"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148058","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148058"}}